C-Reactive Protein Decrease After Postbariatric Abdominoplasty


Variable

Prebariatric

Pre-abdominoplasty

Post-abdominoplasty

Significancea

BMI (kg/m2)

55.7 ± 13.0

31.9 ± 4.6

30.2 ± 3.7

p < 0.001

p = 0.424

Hemoglobin (g/dL)

12.5 ± 2.2

11.7 ± 1.7

11.8 ± 2.4

p = 0.161

p = 0.662

WBC (x103/mm3)

6.6 ± 1.6

5.0 ± 1.1

5.2 ± 1.4

p = 0.006

p = 0.277

Total cholesterol (mg/dL)

176 ± 41

183 ± 12

187 ± 35

p = 0.227

p = 0.246

HDL cholesterol (mg/dL)

51.4 ± 8.4

61.8 ± 6.7

72.6 ± 13.2

p = 0.041

p = 0.049

LDL cholesterol (mg/dL)

110 ± 38

107 ± 14

96.3 ± 14.8

p = 0.817

p = 0.256

VLDL cholesterol (mg/dL)

16.3 ± 3.5

12.3 ± 1.5

13.6 ± 3.7

p = 0.144

p = 0.257

Triglycerides (mg/dL)

80.8 ± 13.0

60.8 ± 6.7

73.8 ± 17.2

p = 0.041

p = 0.095

Glucose (mg/dL)

99.6 ± 26.6

83.5 ± 5.8

86.4 ± 6.5

p = 0.133

p = 0.555

HbA1c (%)

8.5 ± 2.8

5.7 ± 1.6

5.4 ± 1.1

p = 0.038

p = 0.223

C-reactive protein (mg/dL)

6.6 ± 3.3

3.9 ± 2.3

2.2 ± 1.6

p = 0.024

p = 0.008


aFirst significance: prebariatric vs pre-abdominoplasty; second significance: pre-abdominoplasty vs postabdominoplasty



The profile after mastopexy with breast implants revealed some unexpected alterations. These patients presented a lower BMI previous to bariatric and plastic surgeries, besides the sustained anemia in the years following breast reconstruction. On the other hand, a pattern of nutritional stability was presented during the observation period (Table. 31.2).


Table 31.2
Outcome variables in control patients (mastopexy with implants)






























































































Variable

Prebariatric

Preimplant

Postimplant

Significancea

BMI (kg/m2)

43.7 ± 3.6

25.5 ± 2.2

24.6 ± 2.6

p < 0.001

p = 0.233

Hemoglobin (g/dL)

13.2 ± 0.9

12.1 ± 1.0

11.0 ± 1.8

p = 0.017

p = 0.039

WBC (x103/mm3)

7.3 ± 2.2

5.5 ± 1.3

5.5 ± 1.5

p = 0.015

p = 0.558

Total cholesterol (mg/dL)

187 ± 31

151 ± 31

168 ± 35

p = 0.004

p = 0.167

HDL cholesterol (mg/dL)

47.0 ± 9.9

69.4 ± 19.5

66.0 ± 4.1

p = 0.040

p = 0.869

LDL cholesterol (mg/dL)

113 ± 23

70.8 ± 20.8

79.5 ± 25.9

p = 0.006

p = 0.161

VLDL cholesterol (mg/dL)

21.1 ± 14.1

13.6 ± 6.1

15.0 ± 8.4

p < 0.001

p = 0.073

Triglycerides (mg/dL)

159 ± 62

66.7 ± 21.3

75.3 ± 33.1

p = 0.027

p = 0.088

Glucose (mg/dL)

90.4 ± 9.7

83.9 ± 9.4

88.3 ± 3.4

p = 0.027

p = 0.937

HbA1c (%)

5.9 ± 0.3

5.9 ± 0.5

6.0 ± 0.6

p = 0.874

p = 0.667

C-reactive protein (mg/dL)

6.8 ± 2.1

4.6 ± 5.7

3.2 ± 1.0

p = 0.143

p = 0.301


aFirst significance: prebariatric vs preimplant; second significance: preimplant vs postimplant

On Table 31.3, literature data are presented regarding the impact of liposuction and abdominoplasty in several metabolic variables.


Table 31.3
Metabolic evaluation after liposuction and abdominoplasty









































Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Apr 1, 2016 | Posted by in Aesthetic plastic surgery | Comments Off on C-Reactive Protein Decrease After Postbariatric Abdominoplasty

Full access? Get Clinical Tree

Get Clinical Tree app for offline access

Liposuction

Type

Follow-up

Response

14 overweight obese [27]

Large

4 months

Insulin resistance improved, lipids unchanged

45 obese [28]

Large

6 months

Lipids, inflammation improved

123 obese [29]

Large

3 months

Insulin and inflammation improved

15 obese [30]

Large

6 months

Insulin resistance improved

19 normal + obese [31]

Conv.

6 months

Total cholesterol decreased, LDL increased

15 overweight + obese [33]

Conv.